| Literature DB >> 24886954 |
Takeo Azuhata, Kosaku Kinoshita, Daisuke Kawano, Tomonori Komatsu, Atsushi Sakurai, Yasutaka Chiba, Katsuhisa Tanjho.
Abstract
INTRODUCTION: We developed a protocol to initiate surgical source control immediately after admission (early source control) and perform initial resuscitation using early goal-directed therapy (EGDT) for gastrointestinal (GI) perforation with associated septic shock. This study evaluated the relationship between the time from admission to initiation of surgery and the outcome of the protocol.Entities:
Mesh:
Year: 2014 PMID: 24886954 PMCID: PMC4057117 DOI: 10.1186/cc13854
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Figure 1Protocol for gastrointestinal perforation with associated septic shock. The protocol for early infectious source control (EISC) and early goal-directed therapy (EGDT) for gastrointestinal perforation with septic shock was implemented at Nihon University Itabashi Hospital. GI, gastrointestinal; SIRS: systemic inflammatory response syndrome; IVF, intravenous fluids; CVP, central venous pressure; MAP, mean arterial pressure; ScvO2, central venous oxygen saturation. Revised points from the original protocol of Rivers et al. [3]; *in mechanical ventilation control, the target CVP is ≥8 mm Hg; **the original protocol specified dobutamine, but this was not used; ***blood gas analysis (BGA) measurement of ScvO2 in blood drawn from the internal jugular vein via an indwelling catheter.
Primary diseases of all patients
| Colon/rectal diverticulitis | 35 (22.7) | 6 (17.6) |
| Mechanical small bowel obstruction | 27 (17.5) | 3 (8.8) |
| Mesenteric ischemia and necrotic bowel | 21 (l3.6) | 9 (26.5) |
| Idiopathic lower digestive tract perforation | 16 (10.4) | 5 (14.7) |
| Colon/rectal cancer | 15 (9.7) | 0 (0.0) |
| Gastric/duodenal peptic ulcer | 9 (5,8) | 1 (2.9) |
| Non-occlusive mesenteric ischemia | 9 (5.8) | 4 (11,8) |
| Gastric canes | 5 (3.2) | 1 (2.9) |
| Inflammatory bowel disease | 5 (3.2) | 1 (2.9) |
| Sigmoid volvulus | 3 (1.9) | 0 (0.0) |
| Strangulated inguinal/femur hernia | 3 (1.9) | 0 (0.0) |
| Toxic mega-colon | 2 (1.3) | 2 (5.9) |
| Other | 4 (2.6) | 2 (5.9) |
| Total | 154 | 34 |
Baseline characteristics of all patients
| | |
| Age, years, mean ± SD | 66.5 ± 13.9 |
| Male:female ratio | 88:66 |
| | |
| Small intestine | 66 (42.9) |
| Colon | 63 (40.9) |
| Stomach | 8 (5.2) |
| Duodenum | 6 (3.9) |
| Rectum | 7 (4.5) |
| Combinations | 4 (2.6) |
| | |
| SOFA score | 9.14 ± 3.78 |
| APACHE-II score | 24.0 ± 8.62 |
| MOD score | 4.77 ± 3.23 |
| MAP on admission, mmHg | 66.2 ± 29.9 |
| Blood lactate concentration on admission, mmol/L | 5.69 ± 4.03 |
| ScvO2 on admission, % | 58.9 ± 12.4 |
| | |
| Abscess | 0 (0) |
| One quadrant | 0 (0) |
| Two quadrants | 9 (5.8) |
| Three quadrants | 76 (49.4) |
| Four quadrants | 71 (44.8) |
| | |
| Infusion volume within 2 hours of admission, ml | 2858.8 ± 587.5 |
| Infusion volume within 6 hours of admission, ml | 5125.2 ± 712.1 |
| | |
| | 75 (48.7) |
| | 20 (13.0) |
| | 16 (10.4) |
| | 20 (13.0) |
| Methicillin-resistant | 11 (7.1) |
| | 8 (5.2) |
| | 42 (27.3) |
| | 6 (4.0) |
| Yeast/fungi | 11 (7.1) |
| | |
| Initial antimicrobial therapy, appropriate:inappropriate ratio | 124:30 |
| Time from admission to initiation of antimicrobial therapy, hours*, mean ± SD | 2.3 ± 0.3 |
| | |
| Time from admission to initiation of surgery, hours, mean ± SD | 3.1 ± 1.5 |
| Duration of surgery, hours, mean ± SD | 3.4 ± 1.4 |
| Addition of re-laparotomy**, number of patients (%) | 18 (11.7) |
| Damage control laparotomy, number of patients (%) | 0 (0) |
| Open abdominal technique, number of patients (%) | 2 (1.3) |
| 34.7 ± 36.9 | |
| | |
| 28-day | 127 (82.5) |
| 60-day | 120 (77.9) |
SOFA, sequential organ failure assessment; APACHE-II, acute physiology and chronic health evaluation II; MOD, multiple organ dysfunction; MAP, mean arterial pressure; ScvO2, central venous oxygen saturation. *Initiation of antimicrobial therapy was defined as administration of the first antimicrobial agent to the patient. **Re-laparotomy includes both planned laparotomy and unplanned laparotomy with the exception of secondary radical operation for gastric cancer.
Comparison of survivors and non-survivors
| | ||||||
|---|---|---|---|---|---|---|
| | | | | | | |
| Age, years, mean ± SD | 64.3 ± 14.4 | 74.1 ± 8.7 | 0.0002* | 0.95 | 0.88, 1.00 | 0.071 |
| Male:female ratio | 68:52 | 20:14 | 0.82 | | | |
| | | | | | | |
| Small intestine | 51 (42.5) | 15 (44.1) | 0.76 | | | |
| Colon | 49 (40.8) | 14 (41.2) | | | | |
| Stomach | 7 (5.8) | 1 (2.9) | | | | |
| Duodenum | 5 (4.2) | 1 (2.9) | | | | |
| Rectum | 6 (5.0) | 1 (2.9) | | | | |
| Combinations | 2 (1.7) | 2 (5.9) | | | | |
| | | | | | ||
| SOFA score | 8.5 ± 3.3 | 11.5 ± 4.3 | <0.0001* | 0.80 | 0.66, 0.95 | 0.014** |
| APACHE-II score | 22.8 ± 8.5 | 28.1 ± 7.9 | 0.0014* | - | - | - |
| MOD score | 4.3 ± 2.9 | 6.5 ± 3.7 | 0.0004* | - | - | - |
| Mean arterial pressure on admission, mm Hg | 62.3 ± 29.5 | 62.2 ± 31.6 | 0.38 | | | |
| Blood lactate concentration on admission, mmol/L | 5.0 ± 3.6 | 8.1 ± 4.4 | <0.0001* | 0.88 | 0.77, 1.01 | 0.078 |
| ScvO2 on admission, % | 60.8 ± 11.8 | 52.2 ± 12.1 | 0.0003* | 1.04 | 0.99, 1.09 | 0.13 |
| | | | | | | |
| Abscess | 0 (0) | 0 (0) | 0.95 | | | |
| One quadrant | 0 (0) | 0 (0) | | | | |
| Two quadrants | 7 (5.8) | 2 (5.9) | | | | |
| Three quadrants | 60 (50.0) | 16 (47.1) | | | | |
| Four quadrants | 53 (44.2) | 16 (47.1) | | | | |
| | | | | | ||
| Infusion volume within 2 hours of admission, ml | 2915.8 ± 618.5 | 2657.4 ± 409.0 | 0.023* | 1.00 | 1.00, 1.00 | 0.17 |
| Infusion volume within 6 hours of admission,ml | 5153.8 ± 694.0 | 5024.3 ± 775.2 | 0.35 | | | |
| | | | | | | |
| Patients with inappropriate initial antimicrobial therapy, number (%) | 23 (19.2) | 7 (20.6) | 0.85 | | | |
| Time from admission to initiation of antimicrobial therapy, hours# | 2.3 ± 0.32 | 2.3 ± 0.38 | 0.48 | | | |
| | | | | | | |
| Time from admission to initiation of surgery, hours, mean ± SD | 2.6 ± 1.0 | 4.6 ± 1.6 | <0.0001* | 0.29 | 0.16 – 0.47 | <0.0001** |
| Duration of surgery, hours, mean ± SD | 3.4 ± 1.4 | 3.4 ± 1.4 | 0.92 | | | |
| Patients needing re-laparotomy##, number (%) | 13 (10.8) | 5 (14.7) | 0.54 | | | |
| Patients needing open abdominal technique, number (%) | 1 (0.8) | 1 (2.9) | 0.33 | | | |
| * | ** | |||||
All variables with P-value <0.2 in the bivariate model were taken forward to the multivariate model (multiple logistic regression analysis). * meant p-value was less than 0.2. The SOFA score was chosen for the multivariate model from among the SOFA, APACHE-II and MOD scores which had multi-colinearity. The SOFA score and time from admission to initiation of surgery were selected as independent factors associated with 60-day survival by multiple logistic regression analysis with a P-value <0.05. ** meant p-value was less than 0.05. SOFA, sequential organ failure assessment; APACHE-II, acute physiology and chronic health evaluation II; MOD, multiple organ dysfunction; MAP, mean arterial pressure; ScvO2, central venous oxygen saturation. #Initiation of antimicrobial therapy was defined as administration of the first antimicrobial agent to the patient. ##Re-laparotomy includes both planned laparotomy and unplanned laparotomy with the exception of secondary radical operation for gastric cancer.
Figure 2Time from admission to initiation of surgery and 60-day outcome. All patients were classified into 2-hour groups (from 0 to 12 hours) from admission to initiation of surgery. The number of survivors and non-survivors and the survival rate on day 60 are shown. As the time to initiation of surgery increased, survival rate decreased and the survival rate was 0% in the group that waited more than 6 hours. There were no patients who needed more than 10 hours to initiate surgery.